• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

FDA Wants to Use EHRs to Track Drug Safety

Article

The FDA is offering a grant of up to $1 million to turn large amounts of electronic health record data into usable figures highlighting postmarket risks of various drugs.

The FDA is offering a grant of up to $1 million to turn large amounts of electronic health record (EHR) data into usable figures highlighting postmarket risks of various drugs. The goal is for the agency to be able to perform continuous risk/benefit assessments of drugs after they hit the market.

Eligibility for the grant is limited to the Reagan-Udall Foundation through its Innovations in Medical Evidence Development and Surveillance-Methods program.

The FDA announced plans in January to build a database of EHRs as part of the Mini-Sentinel project. There are roughly 150 million patient records online, and the agency is hoping the foundation will develop analytical processes that can turn that raw data into clear safety trends.

Read more at FDA News: http://bit.ly/1Ju7bFy

Related Videos
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Benjamin Scirica, MD, MPH, associate professor of medicine at Harvard Medical School and director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division
Glenn Balasky during a video interview
dr joseph alvarnas
Michael Lynch, MD, UPMC
dr alex jahangir
Fahad Tahir, MAS, MBA, FACHE, Ascension St Thomas
Leland Metheny, MD, University Hospitals Seidman Cancer Center
Andrew Cournoyer
Kelly Harris, APRN
© 2024 MJH Life Sciences
AJMC®
All rights reserved.